BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16530128)

  • 1. The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis.
    Murdolo G; Smith U
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16 Suppl 1():S35-8. PubMed ID: 16530128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflamed adipose tissue, insulin resistance and vascular injury.
    Andersson CX; Gustafson B; Hammarstedt A; Hedjazifar S; Smith U
    Diabetes Metab Res Rev; 2008; 24(8):595-603. PubMed ID: 18756581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipokines--targeting a root cause of cardiometabolic risk.
    Bakhai A
    QJM; 2008 Oct; 101(10):767-76. PubMed ID: 18550581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, inflammation, and insulin resistance.
    Shoelson SE; Herrero L; Naaz A
    Gastroenterology; 2007 May; 132(6):2169-80. PubMed ID: 17498510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin in health and disease.
    Oh DK; Ciaraldi T; Henry RR
    Diabetes Obes Metab; 2007 May; 9(3):282-9. PubMed ID: 17391153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
    Wisse BE
    J Am Soc Nephrol; 2004 Nov; 15(11):2792-800. PubMed ID: 15504932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
    Schernthaner GH; Schernthaner G
    Scand J Clin Lab Invest Suppl; 2005; 240():30-40. PubMed ID: 16112958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones as anti-inflammatory and anti-atherogenic agents.
    Ceriello A
    Diabetes Metab Res Rev; 2008; 24(1):14-26. PubMed ID: 17990280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic complications of obesity: inflated or inflamed?
    Chandalia M; Abate N
    J Diabetes Complications; 2007; 21(2):128-36. PubMed ID: 17331862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance--a common link between type 2 diabetes and cardiovascular disease.
    Lebovitz HE
    Diabetes Obes Metab; 2006 May; 8(3):237-49. PubMed ID: 16634983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inflammatory process of adipose tissue.
    Blüher M
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):24-31. PubMed ID: 18806722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose tissue, inflammation, and cardiovascular disease.
    Berg AH; Scherer PE
    Circ Res; 2005 May; 96(9):939-49. PubMed ID: 15890981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte chemotactic protein-1 and its role in insulin resistance.
    Sell H; Eckel J
    Curr Opin Lipidol; 2007 Jun; 18(3):258-62. PubMed ID: 17495598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of resistin in inflammation and inflammation-related diseases.
    Pang SS; Le YY
    Cell Mol Immunol; 2006 Feb; 3(1):29-34. PubMed ID: 16549046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
    Dandona P; Ghanim H; Chaudhuri A; Mohanty P
    J Diabetes Complications; 2008; 22(1):62-75. PubMed ID: 18191079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidinediones, insulin resistance and obesity: Finding a balance.
    Wilding J
    Int J Clin Pract; 2006 Oct; 60(10):1272-80. PubMed ID: 16981971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.